vs
Astrana Health, Inc.（ASTH）与Magnera Corp（MAGN）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Magnera Corp的1.2倍（$950.5M vs $792.0M），Astrana Health, Inc.净利率更高（0.7% vs -4.3%，领先5.0%），Astrana Health, Inc.同比增速更快（42.9% vs 12.8%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-13.0M），过去两年Magnera Corp的营收复合增速更高（54.9% vs 53.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
ASTH vs MAGN — 直观对比
营收规模更大
ASTH
是对方的1.2倍
$792.0M
营收增速更快
ASTH
高出30.1%
12.8%
净利率更高
ASTH
高出5.0%
-4.3%
自由现金流更多
ASTH
多$7.0M
$-13.0M
两年增速更快
MAGN
近两年复合增速
53.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $792.0M |
| 净利润 | $6.6M | $-34.0M |
| 毛利率 | — | 12.2% |
| 营业利润率 | 1.9% | 1.8% |
| 净利率 | 0.7% | -4.3% |
| 营收同比 | 42.9% | 12.8% |
| 净利润同比 | 184.4% | 43.3% |
| 每股收益（稀释后） | $0.12 | $-0.95 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHMAGN
| Q4 25 | $950.5M | $792.0M | ||
| Q3 25 | $956.0M | — | ||
| Q2 25 | $654.8M | $839.0M | ||
| Q1 25 | $620.4M | $824.0M | ||
| Q4 24 | $665.2M | $702.0M | ||
| Q3 24 | $478.7M | $332.1M | ||
| Q2 24 | $486.3M | $556.0M | ||
| Q1 24 | $404.4M | $558.0M |
净利润ASTHMAGN
| Q4 25 | $6.6M | $-34.0M | ||
| Q3 25 | $373.0K | — | ||
| Q2 25 | $9.4M | $-18.0M | ||
| Q1 25 | $6.7M | $-41.0M | ||
| Q4 24 | $-7.8M | $-60.0M | ||
| Q3 24 | $16.1M | $-15.2M | ||
| Q2 24 | $19.2M | $19.0M | ||
| Q1 24 | $14.8M | $14.0M |
毛利率ASTHMAGN
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 10.7% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 6.2% |
营业利润率ASTHMAGN
| Q4 25 | 1.9% | 1.8% | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | 1.5% | ||
| Q1 25 | 3.3% | 0.5% | ||
| Q4 24 | 0.1% | -3.1% | ||
| Q3 24 | 5.9% | 0.9% | ||
| Q2 24 | 6.2% | 3.1% | ||
| Q1 24 | 7.5% | 3.8% |
净利率ASTHMAGN
| Q4 25 | 0.7% | -4.3% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 1.4% | -2.1% | ||
| Q1 25 | 1.1% | -5.0% | ||
| Q4 24 | -1.2% | -8.5% | ||
| Q3 24 | 3.4% | -4.6% | ||
| Q2 24 | 3.9% | 3.4% | ||
| Q1 24 | 3.7% | 2.5% |
每股收益（稀释后）ASTHMAGN
| Q4 25 | $0.12 | $-0.95 | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | $-0.51 | ||
| Q1 25 | $0.14 | $-1.15 | ||
| Q4 24 | $-0.14 | $-1.69 | ||
| Q3 24 | $0.33 | $-0.33 | ||
| Q2 24 | $0.40 | $0.60 | ||
| Q1 24 | $0.31 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $264.0M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $779.3M | $1.0B |
| 总资产 | $2.2B | $3.9B |
| 负债/权益比越低杠杆越低 | — | 1.86× |
8季度趋势，按日历期对齐
现金及短期投资ASTHMAGN
| Q4 25 | $429.5M | $264.0M | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | $276.0M | ||
| Q1 25 | $260.9M | $282.0M | ||
| Q4 24 | $290.8M | $215.0M | ||
| Q3 24 | $350.3M | $230.0M | ||
| Q2 24 | $327.7M | $33.9M | ||
| Q1 24 | $337.3M | $30.2M |
总债务ASTHMAGN
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $877.4M | ||
| Q1 24 | — | $884.7M |
股东权益ASTHMAGN
| Q4 25 | $779.3M | $1.0B | ||
| Q3 25 | $775.5M | — | ||
| Q2 25 | $765.5M | $1.1B | ||
| Q1 25 | $745.4M | $1.1B | ||
| Q4 24 | $712.7M | $1.1B | ||
| Q3 24 | $704.6M | $2.1B | ||
| Q2 24 | $678.9M | $2.4B | ||
| Q1 24 | $653.5M | $2.4B |
总资产ASTHMAGN
| Q4 25 | $2.2B | $3.9B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.4B | $4.1B | ||
| Q1 25 | $1.3B | $4.1B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | $1.3B | $2.8B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | $1.2B | $1.5B |
负债/权益比ASTHMAGN
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-13.0M |
| 自由现金流率自由现金流/营收 | -0.6% | -1.6% |
| 资本支出强度资本支出/营收 | 0.3% | 1.9% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHMAGN
| Q4 25 | $-2.9M | $2.0M | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $90.9M | $0 | ||
| Q1 25 | $16.6M | $65.0M | ||
| Q4 24 | $-10.9M | $-58.0M | ||
| Q3 24 | $34.0M | $12.2M | ||
| Q2 24 | $23.2M | $38.0M | ||
| Q1 24 | $6.0M | $20.0M |
自由现金流ASTHMAGN
| Q4 25 | $-6.0M | $-13.0M | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | $42.0M | ||
| Q4 24 | $-13.5M | $-74.0M | ||
| Q3 24 | $31.7M | $3.6M | ||
| Q2 24 | $20.4M | $23.0M | ||
| Q1 24 | $5.6M | $12.5M |
自由现金流率ASTHMAGN
| Q4 25 | -0.6% | -1.6% | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | 5.1% | ||
| Q4 24 | -2.0% | -10.5% | ||
| Q3 24 | 6.6% | 1.1% | ||
| Q2 24 | 4.2% | 4.1% | ||
| Q1 24 | 1.4% | 2.2% |
资本支出强度ASTHMAGN
| Q4 25 | 0.3% | 1.9% | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.5% | 2.8% | ||
| Q4 24 | 0.4% | 2.3% | ||
| Q3 24 | 0.5% | 2.6% | ||
| Q2 24 | 0.6% | 2.7% | ||
| Q1 24 | 0.1% | 1.3% |
现金转化率ASTHMAGN
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 2.00× | ||
| Q1 24 | 0.40× | 1.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MAGN
| Other | $451.0M | 57% |
| United States And Canada | $341.0M | 43% |
